×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
9633 views

Modérateur : Pr Jean-Marc Classe

 

18:00
Qu’est-ce que la réponse pathologique complète et quels sous types sont concernés ?
Dr Anne Vincent-Salomon
 
18:15
A qui proposer de la CNA alors que la chirurgie première est faisable et quelles sont les perspectives ?
Dr Mahasti Saghatchian
 
18:30
A qui proposer une chimiothérapie néoadjuvante alors que l’intervention première est faisable et existe-t-il des perspectives de désescalade chirurgicale ?
Dr Marie Bannier
 
18:45
Quel impact sur la chirurgie axillaire ?
Pr Jean-Marc Classe
 
19:00 Débat/discussion - Réponses aux questions

 

Shooting date : 2021-12-21
Last update : 2022-03-09
1 comment
Join the Discussion
  • Bradley Sarnick Farel M. Merci

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Tuesday, February 4th 2025 from 06pm to 07:30pm (GMT+1)
    Honolulu : Tuesday, February 4th 2025 from 07am to 08:30am (GMT+1)
    San Francisco : Tuesday, February 4th 2025 from 09am to 10:30am (GMT+1)
    New York : Tuesday, February 4th 2025 from 12pm to 01:30pm (GMT+1)
    Buenos Aires : Tuesday, February 4th 2025 from 02pm to 03:30pm (GMT+1)
    London / Dublin : Tuesday, February 4th 2025 from 05pm to 06:30pm (GMT+1)
    Paris / Berlin : Tuesday, February 4th 2025 from 06pm to 07:30pm (GMT+1)
    Istanbul : Tuesday, February 4th 2025 from 07pm to 08:30pm (GMT+1)
    Moscou / Dubaï : Tuesday, February 4th 2025 from 09pm to 10:30pm (GMT+1)
    Bangkok : Wednesday, February 5th 2025 from 12am to 01:30am (GMT+1)
    Shanghai : Wednesday, February 5th 2025 from 01am to 02:30am (GMT+1)
    Tokyo : Wednesday, February 5th 2025 from 02am to 03:30am (GMT+1)
    Sydney : Wednesday, February 5th 2025 from 03am to 04:30am (GMT+1)
    Wellington : Wednesday, February 5th 2025 from 05am to 06:30am (GMT+1)

    Prise en charge du cancer du sein métastatique HER2 surexprimé

    Share
    Wednesday, April 20th 2022 from 06pm to 07:30pm (GMT+2)
    Honolulu : Wednesday, April 20th 2022 from 07am to 08:30am (GMT+2)
    San Francisco : Wednesday, April 20th 2022 from 10am to 11:30am (GMT+2)
    New York : Wednesday, April 20th 2022 from 01pm to 02:30pm (GMT+2)
    Buenos Aires : Wednesday, April 20th 2022 from 02pm to 03:30pm (GMT+2)
    Reykjavik : Wednesday, April 20th 2022 from 05pm to 06:30pm (GMT+2)
    London / Dublin : Wednesday, April 20th 2022 from 06pm to 07:30pm (GMT+2)
    Paris / Berlin : Wednesday, April 20th 2022 from 07pm to 08:30pm (GMT+2)
    Istanbul : Wednesday, April 20th 2022 from 08pm to 09:30pm (GMT+2)
    Moscou / Dubaï : Wednesday, April 20th 2022 from 09pm to 10:30pm (GMT+2)
    Bangkok : Thursday, April 21st 2022 from 12am to 01:30am (GMT+2)
    Shanghai : Thursday, April 21st 2022 from 01am to 02:30am (GMT+2)
    Tokyo : Thursday, April 21st 2022 from 02am to 03:30am (GMT+2)
    Sydney : Thursday, April 21st 2022 from 04am to 05:30am (GMT+2)
    Wellington : Thursday, April 21st 2022 from 06am to 07:30am (GMT+2)

    Cancer du sein

    Cycle de formation en oncologie gynécologique et sénologique de l’Institut Curie

    Share
    Thursday, March 10th 2022 from 07pm to 09pm (GMT+1)
    Honolulu : Thursday, March 10th 2022 from 08am to 10am (GMT+1)
    San Francisco : Thursday, March 10th 2022 from 10am to 12pm (GMT+1)
    New York : Thursday, March 10th 2022 from 01pm to 03pm (GMT+1)
    Buenos Aires : Thursday, March 10th 2022 from 03pm to 05pm (GMT+1)
    London / Dublin : Thursday, March 10th 2022 from 06pm to 08pm (GMT+1)
    Paris / Berlin : Thursday, March 10th 2022 from 07pm to 09pm (GMT+1)
    Istanbul : Thursday, March 10th 2022 from 08pm to 10pm (GMT+1)
    Moscou / Dubaï : Thursday, March 10th 2022 from 10pm to 12am (GMT+1)
    Bangkok : Friday, March 11th 2022 from 01am to 03am (GMT+1)
    Shanghai : Friday, March 11th 2022 from 02am to 04am (GMT+1)
    Tokyo : Friday, March 11th 2022 from 03am to 05am (GMT+1)
    Sydney : Friday, March 11th 2022 from 04am to 06am (GMT+1)
    Wellington : Friday, March 11th 2022 from 06am to 08am (GMT+1)

    Changement de paradigme dans les cancers du sein triple négatif métastatique - de la théorie à l...

    Share
    Tuesday, May 14th 2024 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, May 14th 2024 from 07am to 08:30am (GMT+2)
    San Francisco : Tuesday, May 14th 2024 from 10am to 11:30am (GMT+2)
    New York : Tuesday, May 14th 2024 from 01pm to 02:30pm (GMT+2)
    Buenos Aires : Tuesday, May 14th 2024 from 02pm to 03:30pm (GMT+2)
    Reykjavik : Tuesday, May 14th 2024 from 05pm to 06:30pm (GMT+2)
    London / Dublin : Tuesday, May 14th 2024 from 06pm to 07:30pm (GMT+2)
    Paris / Berlin : Tuesday, May 14th 2024 from 07pm to 08:30pm (GMT+2)
    Istanbul : Tuesday, May 14th 2024 from 08pm to 09:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, May 14th 2024 from 09pm to 10:30pm (GMT+2)
    Bangkok : Wednesday, May 15th 2024 from 12am to 01:30am (GMT+2)
    Shanghai : Wednesday, May 15th 2024 from 01am to 02:30am (GMT+2)
    Tokyo : Wednesday, May 15th 2024 from 02am to 03:30am (GMT+2)
    Sydney : Wednesday, May 15th 2024 from 04am to 05:30am (GMT+2)
    Wellington : Wednesday, May 15th 2024 from 06am to 07:30am (GMT+2)

    Développement thérapeutique dans les cancers du sein triples négatifs métastatiques

    Les webinars du réseau FEM-NET

    Share
    Scroll Up